Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients

Jordana L. Soule, Ali J. Olyaei, Tobin A. Boslaugh, Ann M.H. Busch, Jonathan M. Schwartz, Samuel H. Morehouse, John M. Ham, Susan L. Orloff, Patrick J. Healey

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

Background: Recent evidence suggests that new-onset diabetes after transplant (NODAT) adversely affects orthotopic liver transplant (OLTX) patient and graft survival. The objective of this study is to evaluate the effect of hepatitis C infection on the natural history of NODAT. Methods: A retrospective review of 492 OLTX recipients at a single center was conducted from January 1993 to January 2003. Patients were followed for a minimum of 12 months (range 12 months-10 years). The study population consisted of 444 OLTX recipients who were either HCV positive (n = 206) or HCV negative (n = 238). NODAT was defined by the need for antidiabetic medication for at least 7 days starting anytime after OLTX. Statistical analysis was performed by using the Student t test, Kaplan-Meier survival, and chi-square tests. Results: The overall incidence of NODAT was 33% (146/444). There was a significant difference in the development of NODAT between the HCV-positive group (82/206, 40%) and the HCV-negative group (64/238, 27%) (P < .001). Other independent risk factors for development of NODAT were male gender and age >50 years. Conclusion: Hepatitis C infection contributes to the development of diabetes mellitus in OLTX recipients. The mechanisms behind HCV infection and associated NODAT in HCV-positive OLTX recipients warrant further investigation.

Original languageEnglish (US)
Pages (from-to)552-557
Number of pages6
JournalAmerican journal of surgery
Volume189
Issue number5 SPEC. ISS.
DOIs
StatePublished - May 2005

Keywords

  • Hepatitis C infection
  • Liver transplantation
  • New-onset diabetes after transplantation

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients'. Together they form a unique fingerprint.

  • Cite this

    Soule, J. L., Olyaei, A. J., Boslaugh, T. A., Busch, A. M. H., Schwartz, J. M., Morehouse, S. H., Ham, J. M., Orloff, S. L., & Healey, P. J. (2005). Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients. American journal of surgery, 189(5 SPEC. ISS.), 552-557. https://doi.org/10.1016/j.amjsurg.2005.01.033